Corton Capital’s Elanco Animal Health ELAN Stock Holding History

Corton Capital’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-11,477	Closed	-$326K	–	442
2021 Q4	$326K	Buy	+11,477	New	+$357K	0.14%	143

Other funds holding ELAN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

SHCM

Sachem Head Capital Management New York $4.82B AUM 73.38% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Corton Capital's ELAN Position: Q1 2022 in Review

Corton Capital sold out of Elanco Animal Health (ELAN) in Q1 2022, closing a stake of 11,477 shares — an estimated $326K sold.

Corton Capital first reported a position in ELAN in Q4 2021 and held it in 1 quarter. The position peaked at $326K in Q4 2021. 472 funds tracked by Wall St. Rank hold ELAN as of Q1 2022.

Corton Capital reported no remaining Elanco Animal Health position as of Q1 2022 after selling out during the quarter.
Corton Capital sold 11,477 Elanco Animal Health shares in Q1 2022, an estimated $326K.
Corton Capital first reported a position in Elanco Animal Health in Q4 2021 and held it in 1 quarter.
Corton Capital's Elanco Animal Health position peaked at $326K in Q4 2021.
472 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2022.

Based on Corton Capital's 13F filing for Q1 2022, filed 16 May 2022.